Dr Susanne Gerbl-Rieger studied molecular biology, genetic engineering, human genetics, and pharmacology at the Ludwig Maximilian University in Munich, Germany. She received her doctorate in 1990 at the Max Planck Institute for Biochemistry, Technical University of Munich, and started working for TÜV SÜD in 1992, focusing on quality and safety topics in life science. At TÜV SÜD, she worked as expert in genetic engineering and biotechnology, as quality management system auditor for life science companies and as reviewer of design dossiers of medical devices at a European Notified Body. She built up a food and feed certification business and became the CEO and head of the Certification Body of TÜV SÜD Vitacert GmbH. From 2008-2016, she was Director for Compliance at MSOURCE and later CROMSOURCE, a European and US-based CRO. At the same time (2012-2016), she was chairman of the medical device working group of the European Federation of Clinical Research Organisations (EUCROF). She continuously maintained her authorization as medical devices auditor at TÜV SÜD Product Service GmbH. In 2016, she joined the TÜV SÜD Clinical Centre of Excellence (CCE) as Director for Clinical Audits.